首页> 外文期刊>The Journal of Neuroscience: The Official Journal of the Society for Neuroscience >JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.
【24h】

JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.

机译:脊髓星形胶质细胞中JNK诱导的MCP-1产生有助于中枢敏化和神经性疼痛。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Our previous study showed that activation of c-jun-N-terminal kinase (JNK) in spinal astrocytes plays an important role in neuropathic pain sensitization. We further investigated how JNK regulates neuropathic pain. In cultured astrocytes, tumor necrosis factor alpha (TNF-alpha) transiently activated JNK via TNF receptor-1. Cytokine array indicated that the chemokine CCL2/MCP-1 (monocyte chemoattractant protein-1) was strongly induced by the TNF-alpha/JNK pathway. MCP-1 upregulation by TNF-alpha was dose dependently inhibited by the JNK inhibitors SP600125 (anthra[1,9-cd]pyrazol-6(2H)-one) and D-JNKI-1. Spinal injection of TNF-alpha produced JNK-dependent pain hypersensitivity and MCP-1 upregulation in the spinal cord. Furthermore, spinal nerve ligation (SNL) induced persistent neuropathic pain and MCP-1 upregulation in the spinal cord, and both were suppressed by D-JNKI-1. Remarkably, MCP-1 was primarily induced in spinal cord astrocytes after SNL. Spinal administration of MCP-1 neutralizing antibody attenuated neuropathic pain. Conversely, spinal application of MCP-1 induced heat hyperalgesia and phosphorylation of extracellular signal-regulated kinase in superficial spinal cord dorsal horn neurons, indicative of central sensitization (hyperactivity of dorsal horn neurons). Patch-clamp recordings in lamina II neurons of isolated spinal cord slices showed that MCP-1 not only enhanced spontaneous EPSCs but also potentiated NMDA- and AMPA-induced currents. Finally, the MCP-1 receptor CCR2 was expressed in neurons and some non-neuronal cells in the spinal cord. Together, we have revealed a previously unknown mechanism of MCP-1 induction and action. MCP-1 induction in astrocytes after JNK activation contributes to central sensitization and neuropathic pain facilitation by enhancing excitatory synaptic transmission. Inhibition of the JNK/MCP-1 pathway may provide a new therapy for neuropathic pain management.
机译:我们先前的研究表明,脊髓星形胶质细胞中c-jun-N-末端激酶(JNK)的激活在神经性疼痛致敏中起重要作用。我们进一步研究了JNK如何调节神经性疼痛。在培养的星形胶质细胞中,肿瘤坏死因子α(TNF-alpha)通过TNF受体1瞬时激活JNK。细胞因子阵列表明趋化因子CCL2 / MCP-1(单核细胞趋化蛋白-1)被TNF-α/ JNK途径强烈诱导。 TNF-α对MCP-1的上调受到JNK抑制剂SP600125(蒽[1,9-cd]吡唑-6(2H)-one)和D-JNKI-1的剂量依赖性抑制。脊髓注射TNF-α在脊髓中产生JNK依赖性疼痛超敏反应和MCP-1上调。此外,脊髓神经结扎(SNL)引起了脊髓中的持续性神经性疼痛和MCP-1上调,并且都被D-JNKI-1抑制。值得注意的是,MCP-1在SNL后主要在脊髓星形胶质细胞中诱导。脊髓给予MCP-1中和抗体可减轻神经性疼痛。相反,MCP-1的脊柱应用引起浅痛性脊髓背角神经元的热痛觉过敏和细胞外信号调节激酶的磷酸化,表明中枢敏化(背角神经元过度活跃)。分离的脊髓切片的椎板II神经元的膜片钳记录表明,MCP-1不仅增强了自发性EPSC,而且增强了NMDA和AMPA诱导的电流。最后,MCP-1受体CCR2在脊髓神经元和一些非神经元细胞中表达。在一起,我们已经揭示了MCP-1诱导和作用的以前未知的机制。 JNK激活后星形胶质细胞中的MCP-1诱导通过增强兴奋性突触传递来促进中枢敏化和神经性疼痛的缓解。 JNK / MCP-1途径的抑制可能为神经性疼痛管理提供一种新的疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号